Lunger John

Chief Patient Supply Officer at Adaptimmune Therapeutics PLC · on record since Aug 5, 2019
Director at GENOCEA BIOSCIENCES, INC. · on record since Mar 7, 2022

Insider trading activity of Lunger John

Transactions on record: 44; since Aug 5, 2019

Open-market buys: 0

Open-market sells: 28; $217.9K

Companies traded: 2; last filing Feb 20, 2025

Figures computed from official regulatory filings — .

Companies where Lunger John has traded

Adaptimmune Therapeutics PLC43 tx · $217.9K · Feb 20, 2025
GENOCEA BIOSCIENCES, INC.1 tx · Mar 7, 2022

Track record of Lunger John

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lunger John

Co-insiders of Lunger John

BARRIS PETER JAdaptimmune Therapeutics PLC +1
BASKETT FORESTAdaptimmune Therapeutics PLC +1
Behbahani AliAdaptimmune Therapeutics PLC +1
Florence Anthony A. Jr.Adaptimmune Therapeutics PLC +1
MOTT DAVID MAdaptimmune Therapeutics PLC +1
SANDELL SCOTT DAdaptimmune Therapeutics PLC +1
Sonsini Peter W.Adaptimmune Therapeutics PLC +1
Viswanathan RaviAdaptimmune Therapeutics PLC +1
Aakalu Girish NGENOCEA BIOSCIENCES, INC.
Alfieri MichaelGENOCEA BIOSCIENCES, INC.
Allen Andrew RAdaptimmune Therapeutics PLC
Alleva Lawrence MAdaptimmune Therapeutics PLC
Amado RafaelAdaptimmune Therapeutics PLC
BARRETT M JAMESAdaptimmune Therapeutics PLC
BATE KENNETHGENOCEA BIOSCIENCES, INC.
Bertrand William C JRAdaptimmune Therapeutics PLC
Binder-Scholl Gwendolyn KnowltonAdaptimmune Therapeutics PLC
Bitterman KevinGENOCEA BIOSCIENCES, INC.
Bosley KatrineGENOCEA BIOSCIENCES, INC.
Brewer Joanna ElizabethAdaptimmune Therapeutics PLC
Carroll PamelaGENOCEA BIOSCIENCES, INC.
Chang CarmenGENOCEA BIOSCIENCES, INC.
Clark William DGENOCEA BIOSCIENCES, INC.
Cooper Ronald Harold WilfredGENOCEA BIOSCIENCES, INC.
Davis Thomas AndrewGENOCEA BIOSCIENCES, INC.
Duncan Barbara GayleAdaptimmune Therapeutics PLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Adaptimmune Therapeutics PLCListing unverified	Feb 20, 2025	AwardD (derivative)	1,612,032	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Feb 20, 2025	AwardD (derivative)	1,074,696	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2025	Sell	-5,584	0.58 USD	$3.2K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 15, 2025	Sell	-4,268	0.59 USD	$2.5K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 15, 2025	Sell	-5,471	0.59 USD	$3.2K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 15, 2025	Sell	-9,803	0.57 USD	$5.6K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	Sell	-5,309	0.67 USD	$3.6K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	AwardD (derivative)	2,544,432	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	AwardD (derivative)	565,416	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	Sell	-12,805	0.67 USD	$8.6K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	Sell	-4,681	0.79 USD	$3.7K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 12, 2024	Sell	-5,220	0.85 USD	$4.4K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 12, 2024	Sell	-4,009	0.84 USD	$3.4K	SEC
Adaptimmune Therapeutics PLCListing unverified	Aug 1, 2023	Sell	-3,096	0.91 USD	$2.8K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2023	Sell	-4,440	1.86 USD	$8.3K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2023	AwardD (derivative)	314,256	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2023	AwardD (derivative)	190,920	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2023	AwardD (derivative)	1,407,072	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 12, 2023	Sell	-4,973	1.71 USD	$8.5K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 12, 2023	Sell	-3,843	1.75 USD	$6.7K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 4, 2023	Sell	-1,100	1.69 USD	$1.9K	SEC
Adaptimmune Therapeutics PLCListing unverified	Aug 1, 2022	Sell	-2,983	1.77 USD	$5.3K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2022	Sell	-1,973	1.68 USD	$3.3K	SEC
GENOCEA BIOSCIENCES, INC.Listing unverified	Mar 7, 2022	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 18, 2022	Sell	-4,368	3.19 USD	$13.9K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Adaptimmune Therapeutics PLCListing unverified	Feb 20, 2025	AwardD (derivative)	1,612,032	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Feb 20, 2025	AwardD (derivative)	1,074,696	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2025	Sell	-5,584	0.58 USD	$3.2K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 15, 2025	Sell	-4,268	0.59 USD	$2.5K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 15, 2025	Sell	-5,471	0.59 USD	$3.2K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 15, 2025	Sell	-9,803	0.57 USD	$5.6K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	Sell	-5,309	0.67 USD	$3.6K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	AwardD (derivative)	2,544,432	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	AwardD (derivative)	565,416	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	Sell	-12,805	0.67 USD	$8.6K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2024	Sell	-4,681	0.79 USD	$3.7K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 12, 2024	Sell	-5,220	0.85 USD	$4.4K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 12, 2024	Sell	-4,009	0.84 USD	$3.4K	SEC
Adaptimmune Therapeutics PLCListing unverified	Aug 1, 2023	Sell	-3,096	0.91 USD	$2.8K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2023	Sell	-4,440	1.86 USD	$8.3K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2023	AwardD (derivative)	314,256	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2023	AwardD (derivative)	190,920	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 17, 2023	AwardD (derivative)	1,407,072	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 12, 2023	Sell	-4,973	1.71 USD	$8.5K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 12, 2023	Sell	-3,843	1.75 USD	$6.7K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 4, 2023	Sell	-1,100	1.69 USD	$1.9K	SEC
Adaptimmune Therapeutics PLCListing unverified	Aug 1, 2022	Sell	-2,983	1.77 USD	$5.3K	SEC
Adaptimmune Therapeutics PLCListing unverified	Jul 5, 2022	Sell	-1,973	1.68 USD	$3.3K	SEC
GENOCEA BIOSCIENCES, INC.Listing unverified	Mar 7, 2022	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Adaptimmune Therapeutics PLCListing unverified	Jan 18, 2022	Sell	-4,368	3.19 USD	$13.9K	SEC